2018
Vaccine (2018). 10.1016/j.vaccine.2018.02.062.
2018
Scientific reports, (2018).8 1 10.1038/s41598-018-29515-2.
2018
Human vaccines & immunotherapeutics, (2018).15 2 10.1080/21645515.2018.1532257.
2018
Social science & medicine (1982), (2018).203, 10.1016/j.socscimed.2018.03.008.
2018
PloS one, (2018).13 7 10.1371/journal.pone.0200715.
Benefits risk analysis of vaccination of pregnant women with rVSV-ZEBOV as part of expanded access programme.
2018
(2018).
2018
International journal of cancer Journal international du cancer, (2018).143 2 10.1002/ijc.31321.
2018
Human vaccines & immunotherapeutics, (2018).14 11 10.1080/21645515.2018.1488562.
2018
Implementation science, (2018).13 1 10.1186/s13012-018-0824-8.